1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
or a physiologically acceptable salt thereof, for the treatment of
sub-type anxiety disorders chosen from the sub-types: panic disorder with
or without agoraphobia, agoraphobia, obsessive-compulsive spectrum
disorders, social phobia, posttraumatic stress disorder, acute stress
indication or generalized anxiety disorder, bipolar disorders, mania,
dementia, substance-related disorders, sexual dysfunctions, eating
disorders, obesity, anorexia, and fibromyalgia. A preferred salt is
1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
hydrochloride.